The approval follows PEGASUS Phase III trial assessing Palynziq efficacy and safety compared to diet alone in adolescents ...
The swallowable gastric balloon has gained FDA approval for short-term weight loss in adults with obesity. Learn more.
Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...
Treatment with PALYNZIQ led to statistically significant blood phenylalanine (Phe) lowering compared to diet alone in pivotal ...
It's rare to make it through an episode of your favorite show without seeing a commercial for a prescription drug that ...
Retatrutide helped trial participants lose up to 28.7% of their body weight, but experts warn about excessive weight loss.
The Gobles resident faces up to five years in prison for allegedly selling unapproved versions of semaglutide and tirzepatide ...
The newly-approved device requires only that patients swallow it in their doctor's office to achieve weight loss, according ...
The U.S. Food and Drug Administration said on Thursday it approved Boehringer Ingelheim's drug for patients with a type of advanced lung cancer who have received prior treatment, marking the second ...
An experimental therapy for a rare blood cancer was rejected by the FDA though internal reviewers had recommended it be cleared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results